Ethyl 6-chloroimidazo[1,2-b]pyridazine-3-carboxylate, 98.0%, 100g

(R)-TERT-BUTYL 2-(2-(METHYLAMINO)THIAZOL-4-YL)PYRROLIDINE-1-CARBOXYLATE, 90.0%, 5g

5-Bromo-6-fluoropyridin-2(1H)-one, 97%, 1g

2-Amino-5-chloro-3-fluorophenol, 97%, 1g

(2S,4R)-1-Acetyl-4-hydroxypyrrolidine-2-carboxylic acid, 95.0%, 50g

4-Bromo-3-chloro-1H-indazole, 95.0%, 25g

ROTI®DipSlide PCA/RBCplus

Oxion Inverso OX.2053-PLPH-ICSI with LWD Plan phase 10x/20x/40x objectives, ICSI equipment and XY cross table

Gadolinium(III) chloride hexahydrate, 95.0%, 1g

5,6,7,8-Tetrahydroimidazo[1,2-a]pyrimidine hydrochloride, 95.0%, 1g

1-(4-Chlorobutyl)-4-fluorobenzene, 95.0%, 250mg

4-Chloro-3,5-dinitrobenzonitrile>98.0%(GC)(T)5g

Filtration unit with SFCA membrane Pore size 0.45 μm, 150 ml, 150 ml, 50 mm, 12 Piece(s)